Skip to Content

W 273 (Lamotrigine extended-release 100 mg)

Pill imprint W 273 has been identified as Lamotrigine extended-release 100 mg.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; borderline personality disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamotrigine extended-release 100 mg W 273
Discount Card Promo
Lamotrigine extended-release
Imprint:
W 273
Strength:
100 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Wockhardt USA LLC
National Drug Code (NDC):
64679-0273
Inactive Ingredients:
diethyl phthalate
ferric oxide red
ferric oxide yellow
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
magnesium silicate
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide